Avid Bioservices to Go Private in $1.1 Billion Deal
Avid Bioservices Chief Executive Nick Green said the company’s board considered several options before determining to move forward as a private company under new owners.
GHO and Ampersand Capital to acquire Avid Bioservices
The definitive merger agreement stipulates that GHO and Ampersand will purchase all outstanding shares of Avid.
Avid Bioservices to be acquired for $1.1B in cash by GHO, Ampersand
Avid Bioservices (CDMO) has agreed to be acquired by GHO Capital Partners and Ampersand Capital Partners through a cash deal that values the company at $1.1B. Read more here.
Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction
Under the terms of the merger agreement, GHO and Ampersand would acquire all the outstanding shares held by Avid’s stockholders for $12.50 per share in cash. The per share purchase price represents a 13.
GHO Capital, Ampersand Capital to buy Avid Bioservices in $1.1bn deal
GHO Capital Partners and Ampersand Capital Partners have agreed to acquire Avid Bioservices, a biologics contract development and manufacturing organization, in an all-cash transaction valued at around $1.1 billion. Avid provides development and manufacturing services to biotechnology and pharmaceutical companies. It is based in Tustin, California.
Avid Bioservices to go private in $1.1bn private equity deal
The $12.50-per-share takeover has been approved by Avid's board and is scheduled to close in the first quarter of 2025, subject to Avid shareholder approval and meeting the usual regulatory conditions. Shares in the company rose 4% after the deal was announced and another 12% in after-hours trading.
Avid Bioservices to be Acquired in $1.1 Billion Deal
Avid Bioservices ( (CDMO) ) just unveiled an announcement. Avid Bioservices, a biologics contract development and manufacturing organization,
Avid Bioservices to be taken private by GHO, Ampersand in $1.1 billion deal
Avid Bioservices said on Wednesday that it would be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners in a deal valued at about $1.1 billion. GHO and Ampersand have offered $12.
Business Wire4h
CDMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avid Bioservices, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Avid Bioservices, Inc. (NASDAQ: CDMO) to ...
FiercePharma14h
Biologics CDMO Avid Bioservices to go private with $1.1B sale to Ampersand, GHO Capital
This week, biologics CDMO Avid Bioservices revealed that it’s agreed to be acquired by funds managed by Ampersand and ...
Craig-Hallum Sticks to Its Buy Rating for Avid Bioservices (CDMO)
Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Avid Bioservices (CDMO – Research Report) today. The company’s shares ...
Benzinga.com21h
Avid Bioservices (NASDAQ:CDMO) Stock, Insider Trading Activity
At Avid Bioservices Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of -shares worth -, meanwhile, insiders have report no purchases ...
Hershey, Upwork And 3 Stocks To Watch Heading Into Thursday
Wall Street expects The Hershey Company HSY to report quarterly earnings at $2.56 per share on revenue of $3.08 billion ...
PharmTech9h
Avid Bioservices Acquired by GHO Capital Partners and Ampersand Capital Partners
The merger agreement is valued at approximately $1.1 billion. Avid Bioservices, a biologics contract development and manufacturing organization (CDMO), announced on Nov. 6, 2024 that it has ...